Prevalence of erythrocyte hemoglobin H inclusions in unselected patients with myelodysplastic syndromes or myeloproliferative disorders

Prevalence of erythrocyte hemoglobin H inclusions in unselected patients with myelodysplastic syndromes or myeloproliferative disorders

Bibliographic Details
Main Authors:	Steensma, P, Porcher, J, Hanson, C, Lathrop, C, Lasho, T, Tefferi, A, Higgs, D
Format:	Conference item
Published:	2007

Similar Items

Prevalence of erythrocyte haemoglobin H inclusions in unselected patients with clonal myeloid disorders.
by: Steensma, D, et al.
Published: (2007)

MYELODYSPLASTIC/MYELOPROLIFERATIVE DISEASES
by: I. N. Subortseva, et al.
Published: (2017-01-01)

The use of genetic tests to diagnose and manage patients with myeloproliferative and myeloproliferative/myelodysplastic neoplasms, and related disorders
by: Cross, NCP, et al.
Published: (2021)

A novel splicing mutation in the gene encoding the chromatin-associated factor ATRX associated with acquired hemoglobin H disease in myelodysplastic syndrome (ATMDS)
by: Steensma, D, et al.
Published: (2004)

Somatic point mutations in RUNX1/CBFA2/AML1 are common in high-risk myelodysplastic syndrome, but not in myelofibrosis with myeloid metaplasia
by: Steensma, D, et al.
Published: (2004)

Somatic point mutations in RUNX1/CBFA2/AML1 are common in high-risk myelodysplastic syndrome, but not in myelofibrosis with myeloid metaplasia.
by: Steensma, D, et al.
Published: (2005)

Hybrid or Mixed Myelodysplastic/Myeloproliferative Disorders – Epidemiological Features and Overview
by: Andrea Kuendgen, et al.
Published: (2021-11-01)

Genetic Aspects of Myelodysplastic/Myeloproliferative Neoplasms
by: Laura Palomo, et al.
Published: (2021-04-01)

Comparison and Implications of Mutational Profiles of Myelodysplastic Syndromes, Myeloproliferative Neoplasms, and Myelodysplastic/Myeloproliferative Neoplasms: A Meta-Analysis
by: Ziqi Wan, et al.
Published: (2020-10-01)

Myelodysplastic/myeloproliferative neoplasms with ring sideroblasts and thrombocytosis (MDS/MPN-RS-T): Mayo-Moffitt collaborative study of 158 patients
by: Abhishek A. Mangaonkar, et al.
Published: (2022-02-01)

Neutrophil PRV-1 gene expression in myeloproliferative, myelodysplastic and reactive blood disorders
by: Zhang, J, et al.
Published: (2004)

Myelodysplastic and myeloproliferative diseases in children: current concepts
by: Vyas, P
Published: (2014)

Allogeneic Hematopoietic Stem Cell Transplantation for Mixed or Overlap Myelodysplastic/Myeloproliferative Disorders
by: Argiris Symeonidis, et al.
Published: (2022-08-01)

Acquired alpha-thalassemia in association with myelodysplastic syndrome and other hematologic malignancies.
by: Steensma, D, et al.
Published: (2005)

Examining disease boundaries: Genetics of myelodysplastic/myeloproliferative neoplasms
by: Michael J. Hochman, et al.
Published: (2021-08-01)

Myelodysplastic syndrome/myeloproliferative neoplasm with ringed sideroblasts and thrombocytosis
by: Azka Tasleem, et al.
Published: (2021-11-01)

Clinical significance of SF3B1 mutations in myelodysplastic syndromes and myelodysplastic/myeloproliferative neoplasms.
by: Malcovati, L, et al.
Published: (2011)

Molecular Progression of Myeloproliferative and Myelodysplastic/Myeloproliferative Neoplasms: A Study on Sequential Bone Marrow Biopsies
by: Magdalena M. Brune, et al.
Published: (2021-11-01)

Definitions, Biology, and Current Therapeutic Landscape of Myelodysplastic/Myeloproliferative Neoplasms
by: Margo B. Gerke, et al.
Published: (2023-07-01)

The association of bladder myeloid sarcoma and unclassified myelodysplastic/myeloproliferative disease
by: Mehmet Sönmez, et al.
Published: (2009-06-01)

Clinical management of myelodysplastic syndrome/myeloproliferative neoplasm overlap syndromes
by: Joseph A. Clara, et al.
Published: (2016-09-01)

DHPLC analysis of the ATRX gene in myelodysplastic syndrome (MDS) associated with acquired alpha thalassemia (AT-MDS): Novel mutation detection despite somatic mosaicism.
by: Steensma, D, et al.
Published: (2003)

Myelodysplastic Syndromes and Myelodysplastic Syndromes/Myeloproliferative Neoplasms: A Real-World Experience From a Developing Country
by: Abdalla Awidi, et al.
Published: (2024-02-01)

Acquired somatic ATRX mutations in myelodysplastic syndrome associated with alpha thalassemia (ATMDS) convey a more severe hematologic phenotype than germline ATRX mutations.
by: Steensma, D, et al.
Published: (2004)

Efficacy of lenalidomide in myelodysplastic/myeloproliferative neoplasms with ring sideroblasts and an extreme platelet count
by: Marion Divoux, et al.
Published: (2020-09-01)

Assessing karyotype precision by microarray-based comparative genomic hybridization in the myelodysplastic/myeloproliferative syndromes
by: Forman Stephen J, et al.
Published: (2010-11-01)

A novel mutation in the last exon of ATRX in a patient with alpha-thalassemia myelodysplastic syndrome.
by: Costa, D, et al.
Published: (2006)

Blast phase myeloproliferative neoplasm: contemporary review and 2024 treatment algorithm
by: Ayalew Tefferi, et al.
Published: (2023-07-01)

Myelodysplastic syndrome/myeloproliferative neoplasm, unclassifiable; rare cause of granulocytic sarcoma: A diagnostic dilemma
by: Prakas Kumar Mandal, et al.
Published: (2016-01-01)

Deletion of the alpha-globin gene cluster as a cause of acquired alpha-thalassemia in myelodysplastic syndrome.
by: Steensma, D, et al.
Published: (2004)

Cliticization as Unselective Attract
by: Lea Nash, et al.
Published: (2002-12-01)

A Case of SF3B1-Positive Myelodysplastic/Myeloproliferative Neoplasm with Ring Sideroblasts and Thrombocytosis
by: Alejandro Lazo-Langner, et al.
Published: (2019-02-01)

Myelodysplastic syndrome/myeloproliferative neoplasm – ring sideroblast with myelofibrosis – A diagnostic dilemma/? A distinct entity
by: Amandeep Talwar, et al.
Published: (2021-01-01)

Prevalence and Prognosis of Fever Symptoms, Hypo-, and Hyperthermia in Unselected Emergency Patients
by: Alexandra Malinovska, et al.
Published: (2021-12-01)

Gene aberrations and methylation analysis of JAK/stat and toll-like receptor downstream signalling in BCR-ABL-negative myeloproliferative neoplasms and myelodysplastic syndrome/myeloproliferative neoplasms overlap syndromes
by: Cai, Chia Yuh
Published: (2021)

P754: INITIAL RESULTS OF PHASE I/II STUDY OF AZACITIDINE IN COMBINATION WITH QUIZARTINIB FOR PATIENTS WITH MYELODYSPLASTIC SYNDROME AND MYELODYSPLASTIC/MYELOPROLIFERATIVE NEOPLASM WITH FLT3 OR CBL MUTATION
by: T. Abuasab, et al.
Published: (2022-06-01)

Clinical, Histopathological and Molecular Spectrum of Cutaneous Lesions in Myelodysplastic Syndrome and Myeloproliferative Neoplasms (MDS/MPN): An Integrative Review
by: Lucía Prieto-Torres, et al.
Published: (2023-12-01)

Myelodysplastic Syndromes/Myeloproliferative Overlap Neoplasms and Differential Diagnosis in the WHO and ICC 2022 Era: A Focused Review
by: Diletta Fontana, et al.
Published: (2023-06-01)

Recurrent bilateral adrenal infarction with myelodysplastic/myeloproliferative neoplasm-unclassifiable (MDS/MPN-U): a case report
by: Yoshitomo Hoshino, et al.
Published: (2023-06-01)

Successful Imatinib Treatment for Systemic Mastocytosis Associated With Myelodysplastic/Myeloproliferative Neoplasm: Report of a Case and Literature Review
by: Enrico Barozzi, et al.
Published: (2022-01-01)